Urogen Pharma Competitors and Similar CompaniesClear all
Urogen Pharma's competitors and similar companies include ESSA Pharma, Fennec Pharma and Rasna Therapeutics.
 ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. | ||
Founding Date | Founding Date 2004 | Founding Date 2009 | Founding Date 1996 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations US HQ | Locations New York, US HQ Greater London, GB Doylestown, US |
Employees | Employees 194362% increase | Employees 35 | Employees 433% increase | Employees N/A |
Valuation ($) | Valuation ($) 515.9 m | Valuation ($) 240 m | Valuation ($) 129.4 m | Valuation ($) 3.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($153.5m) (FY, 2025) | Net income ($28.5m) (FY, 2024) | Net income ($9.7m) (FY, 2025) | Net income ($4.4m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 74.1m | Total funding raised $ 2.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View companyRasna Therapeutics
HQ
New York, US
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View company